COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID

COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID

The present invention relates to the combination of PM01183 with several anticancer drugs, in particular other anticancer drugs selected from antitumor platinum coordination complexes, antimetabolites, mitotic inhibitors, anticancer antibiotics, topoisomerase I and/or II inhibitors, proteasome inhib...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: García Fernández, Luis Francisco, Guillén Navarro, María José, Santamaría Núñez, Gema, Moneo Ocaña, Victoria, Galmarini, Carlos María, Avilés Marín, Pablo Manuel
Format: Patent
Sprache:hrv ; eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator García Fernández, Luis Francisco
Guillén Navarro, María José
Santamaría Núñez, Gema
Moneo Ocaña, Victoria
Galmarini, Carlos María
Avilés Marín, Pablo Manuel
description The present invention relates to the combination of PM01183 with several anticancer drugs, in particular other anticancer drugs selected from antitumor platinum coordination complexes, antimetabolites, mitotic inhibitors, anticancer antibiotics, topoisomerase I and/or II inhibitors, proteasome inhibitors, histone deacetylase inhibitors, nitrogen mustard alkylating agents, nitrosourea alkylating agents, nonclassical alkylating agents, estrogen antagonists, androgen antagonists, mTOR inhibitors, tyrosine kinase inhibitors, and other agents selected from aplidine, ET-743, PM02734 and PM00104, and the use of these combinations in the treatment of cancer.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HRP20190554TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HRP20190554TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HRP20190554TT13</originalsourceid><addsrcrecordid>eNrjZNBz9vd18vRzDPH091MI8XANcgyIVAj3DPFQcPQDohDPkFBf_yAFRx9vRx9_TxceBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhLvERRgZGBoaWBqahISYmhMnCoAlLsnTg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID</title><source>esp@cenet</source><creator>García Fernández, Luis Francisco ; Guillén Navarro, María José ; Santamaría Núñez, Gema ; Moneo Ocaña, Victoria ; Galmarini, Carlos María ; Avilés Marín, Pablo Manuel</creator><creatorcontrib>García Fernández, Luis Francisco ; Guillén Navarro, María José ; Santamaría Núñez, Gema ; Moneo Ocaña, Victoria ; Galmarini, Carlos María ; Avilés Marín, Pablo Manuel</creatorcontrib><description>The present invention relates to the combination of PM01183 with several anticancer drugs, in particular other anticancer drugs selected from antitumor platinum coordination complexes, antimetabolites, mitotic inhibitors, anticancer antibiotics, topoisomerase I and/or II inhibitors, proteasome inhibitors, histone deacetylase inhibitors, nitrogen mustard alkylating agents, nitrosourea alkylating agents, nonclassical alkylating agents, estrogen antagonists, androgen antagonists, mTOR inhibitors, tyrosine kinase inhibitors, and other agents selected from aplidine, ET-743, PM02734 and PM00104, and the use of these combinations in the treatment of cancer.</description><language>hrv ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190503&amp;DB=EPODOC&amp;CC=HR&amp;NR=P20190554T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25568,76551</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190503&amp;DB=EPODOC&amp;CC=HR&amp;NR=P20190554T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>García Fernández, Luis Francisco</creatorcontrib><creatorcontrib>Guillén Navarro, María José</creatorcontrib><creatorcontrib>Santamaría Núñez, Gema</creatorcontrib><creatorcontrib>Moneo Ocaña, Victoria</creatorcontrib><creatorcontrib>Galmarini, Carlos María</creatorcontrib><creatorcontrib>Avilés Marín, Pablo Manuel</creatorcontrib><title>COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID</title><description>The present invention relates to the combination of PM01183 with several anticancer drugs, in particular other anticancer drugs selected from antitumor platinum coordination complexes, antimetabolites, mitotic inhibitors, anticancer antibiotics, topoisomerase I and/or II inhibitors, proteasome inhibitors, histone deacetylase inhibitors, nitrogen mustard alkylating agents, nitrosourea alkylating agents, nonclassical alkylating agents, estrogen antagonists, androgen antagonists, mTOR inhibitors, tyrosine kinase inhibitors, and other agents selected from aplidine, ET-743, PM02734 and PM00104, and the use of these combinations in the treatment of cancer.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNBz9vd18vRzDPH091MI8XANcgyIVAj3DPFQcPQDohDPkFBf_yAFRx9vRx9_TxceBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhLvERRgZGBoaWBqahISYmhMnCoAlLsnTg</recordid><startdate>20190503</startdate><enddate>20190503</enddate><creator>García Fernández, Luis Francisco</creator><creator>Guillén Navarro, María José</creator><creator>Santamaría Núñez, Gema</creator><creator>Moneo Ocaña, Victoria</creator><creator>Galmarini, Carlos María</creator><creator>Avilés Marín, Pablo Manuel</creator><scope>EVB</scope></search><sort><creationdate>20190503</creationdate><title>COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID</title><author>García Fernández, Luis Francisco ; Guillén Navarro, María José ; Santamaría Núñez, Gema ; Moneo Ocaña, Victoria ; Galmarini, Carlos María ; Avilés Marín, Pablo Manuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HRP20190554TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>hrv ; eng</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>García Fernández, Luis Francisco</creatorcontrib><creatorcontrib>Guillén Navarro, María José</creatorcontrib><creatorcontrib>Santamaría Núñez, Gema</creatorcontrib><creatorcontrib>Moneo Ocaña, Victoria</creatorcontrib><creatorcontrib>Galmarini, Carlos María</creatorcontrib><creatorcontrib>Avilés Marín, Pablo Manuel</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>García Fernández, Luis Francisco</au><au>Guillén Navarro, María José</au><au>Santamaría Núñez, Gema</au><au>Moneo Ocaña, Victoria</au><au>Galmarini, Carlos María</au><au>Avilés Marín, Pablo Manuel</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID</title><date>2019-05-03</date><risdate>2019</risdate><abstract>The present invention relates to the combination of PM01183 with several anticancer drugs, in particular other anticancer drugs selected from antitumor platinum coordination complexes, antimetabolites, mitotic inhibitors, anticancer antibiotics, topoisomerase I and/or II inhibitors, proteasome inhibitors, histone deacetylase inhibitors, nitrogen mustard alkylating agents, nitrosourea alkylating agents, nonclassical alkylating agents, estrogen antagonists, androgen antagonists, mTOR inhibitors, tyrosine kinase inhibitors, and other agents selected from aplidine, ET-743, PM02734 and PM00104, and the use of these combinations in the treatment of cancer.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language hrv ; eng
recordid cdi_epo_espacenet_HRP20190554TT1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T05%3A26%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Garc%C3%ADa%20Fern%C3%A1ndez,%20Luis%20Francisco&rft.date=2019-05-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHRP20190554TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true